| Literature DB >> 34408641 |
Yanan Qiao1, Xuwen He2, Junying Zhang2, Ying Liang3, Wen Shao1, Zhanjun Zhang2, Sihang Zhang4, Dantao Peng1.
Abstract
OBJECTIVE: Emerging evidence suggests that white matter (WM) disruption is associated with the incidence of subcortical vascular cognitive impairment (SVCI). However, our knowledge regarding this relationship in the early stage of SVCI is limited. We aimed to investigate the associations between WM disruptions and cognitive declines at the early stage of SVCI.Entities:
Keywords: cognitive impairment; diffusion tensor imaging; subcortical ischemic vascular disease; subcortical vascular cognitive impairment; white matter hyperintensities
Year: 2021 PMID: 34408641 PMCID: PMC8364958 DOI: 10.3389/fnagi.2021.681208
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
FIGURE 1Flowcharts for study enrollment of case participants and control participants. Pre-SVCI is subcortical ischemic vascular disease with normal global cognition measures.
Demographics and clinical characteristics of each group.
| Pre-SVCI ( | H ( | t/X2 | Sig | |
| Sex (male/female) | 10/12 | 7/12 | 0.312 | 0.577 |
| Age (years) | 65.14 ± 1.67 | 61.58 ± 1.80 | −1.543 | 0.131 |
| Education (years) | 12.36 ± 0.76 | 12.68 ± 0.81 | 0.304 | 0.763 |
| Smoking (n) | 8 (36.4%) | 5 (26.3%) | 0.475 | 0.491 |
| Alcohol (n) | 2 (9.1%) | 0 (0%) | – | 0.490 |
| HT (n) | 11 (50.0%) | 2 (10.5%) | 5.627 | 0.018* |
| HC (n) | 11 (50.0%) | 4 (21.1%) | 2.540 | 0.111 |
| CAD (n) | 4 (18.2%) | 2 (10.5%) | 0.062 | 0.804 |
| DM (n) | 8 (36.4%) | 5 (26.3%) | 0.475 | 0.491 |
Neuropsychological tests result for each group.
| Pre-SVCI ( | H ( | Effect sizes (standardized beta) | |||
|
| |||||
| MMSE MoCA | 27.95 ± 1.53 26.55 ± 0.67 | 28.79 ± 1.36 27.97 ± 0.74 | −1.302 −3.984 | −0.208 −0.544 | 0.201 <0.001* |
|
| |||||
| AVLT-delay | 7.73 ± 5.86 | 6.95 ± 2.46 | 0.132 | 0.022 | 0.895 |
| AVLT-total | 32.55 ± 7.42 | 33.79 ± 6.75 | −0.444 | −0.076 | 0.660 |
| R-O delay | 18.23 ± 6.89 | 17.47 ± 7.71 | −0.696 | −0.115 | 0.491 |
|
| |||||
| R-O copy | 34.55 ± 2.24 | 35.37 ± 0.96 | −2.151 | −0.405 | 0.045* |
| CDT | 24.00 ± 6.44 | 24.32 ± 6.77 | 0.176 | 0.030 | 0.861 |
|
| |||||
| Stroop C-time | 98.57 ± 10.35 | 78.82 ± 11.40 | 1.982 | 0.311 | 0.055 |
| Stroop C-right | 47.80 ± 2.26 | 45.31 ± 2.49 | 1.186 | 0.194 | 0.243 |
| TMT b | 163.57 ± 15.56 | 113.71 ± 17.16 | 5.746 | 0.700 | <0.001* |
|
| |||||
| BNT | 26.68 ± 1.89 | 25.79 ± 2.02 | 1.302 | 0.213 | 0.201 |
| CVFT | 42.00 ± 12.98 | 49.58 ± 9.36 | −1.946 | −0.312 | 0.059 |
|
| |||||
| SDMT | 34.77 ± 17.08 | 39.37 ± 7.96 | −0.633 | −0.099 | 0.531 |
| TMTa | 51.82 ± 31.76 | 51.84 ± 12.23 | −0.087 | −0.015 | 0.931 |
Group comparisons of mean DTI diffusion metrics of white matter tracts in two groups.
| Pre-SVCI ( | H ( | Effect sizes (standardized beta) | |||
|
| |||||
| FA | 0.3778 ± 0.0213 | 0.4013 ± 0.0213 | −4.150 | −0.566 | <0.001* |
|
| |||||
| DA (10–3) | 1.290 ± 0.495 | 1.250 ± 0.260 | 2.549 | 0.402 | 0.015 |
|
| |||||
| DA (10–3) | 1.084 ± 0.415 | 1.046 ± 0.198 | 3.269 | 0.471 | 0.002 |
|
| |||||
| MD (10–4) | 8.025 ± 4.056 | 7.749 ± 3.484 | 2.885 | 0.436 | 0.007 |
| DA (10–3) | 1.329 ± 0.441 | 1.297 ± 0.443 | 2.352 | 0.367 | 0.024 |
|
| |||||
| MD (10–4) | 8.129 ± 3.673 | 7.887 ± 2.014 | 2.294 | 0.361 | 0.028 |
| DA (10–3) | 1.277 ± 0.438 | 1.250 ± 0.261 | 2.307 | 0.366 | 0.027 |
|
| |||||
| MD (10–4) | 7.938 ± 3.569 | 7.537 ± 2.232 | 4.331 | 0.586 | <0.001* |
| DA(10–3) | 1.103 ± 0.457 | 1.058 ± 0.261 | 3.893 | 0.550 | <0.001* |
| DR(10–4) | 6.391 ± 0.366 | 6.016 ± 0.247 | 3.399 | 0.505 | 0.002 |
|
| |||||
| FA | 0.43795 ± 0.0219 | 0.4575 ± 0.0301 | −2.337 | −0.369 | 0.025 |
| MD (10–4) | 7.703 ± 2.302 | 7.436 ± 1.519 | 3.841 | 0.540 | <0.001* |
| DR(10–4) | 5.690 ± 0.265 | 5.371 ± 0.226 | 3.780 | 0.538 | <0.001* |
FIGURE 2The tracts where diffusion metrics remained significant between the two groups after Bonferroni correction for multiple comparisons. (A) Mean FA values of ACR.R; (B) Mean MD, DA, and DR values of EC.L; (C), mean FA, MD, and DR values of IFOF.R. *is significant at p < 0.05/40 after Bonferroni correction. FA, fractional anisotropy, MD, mean diffusivity; DA, axial diffusivity; DR, radial diffusivity; pre-SVCI, subcortical ischemic vascular disease with normal global cognition measures; H, healthy; L, left; R, right; ACR, anterior corona radiata; EC, external capsule; IFOF, inferior fronto-occipital fasciculus.
FIGURE 3The significant correlations between ROI-wise diffusion metrics and behaviors in the pre-SVCI group and the H group after Bonferroni correction for multiple comparisons. (A) MoCA. (B) R-O delay. (C) MMSE. MoCA, Montreal cognitive assessment; R-O delay, Rey–Osterrieth Complex Figure delay tests; MMSE, Mini-Mental State Examination; FA, fractional anisotropy, MD, mean diffusivity; pre-SVCI, subcortical ischemic vascular disease with normal global cognition measures; H, healthy; L, left; R, right; ACR, anterior corona radiata; IFOF, inferior fronto-occipital fasciculus; PTR, posterior thalamic radiation.